Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models. - Li, Shulin; Hoefnagel, Sanne J. M.; Read, Matthew; Meijer, Sybren; van Berge Henegouwen, Mark I.; Gisbertz, Suzanne S.; Bonora, Elena; Liu, David S. H.; Phillips, Wayne A.; Calpe, Silvia; Correia, Ana C. P.; Sancho-Serra, Maria D. C.; et al. (Cellular Oncology (2211-3428), 2022)